CLDN1 and gastrointestinal stromal tumor: Lastly, CLDN1 expression significantly increased in primary high-risk GIST, which correlated with activation of the FGFR survival pathway, thereby revealing an essential role of CLDN1 in GIST resistance to IM and disease progression.